Study Results Confirm Usability And Safety Of Smartpan When Used As Indicator Of Pancreatic Leakage
April 27 (Reuters) - Magle Chemoswed Holding AB
MAGLE.ST :
* POSITIVE RESULTS FROM POST-MARKET CLINICAL FOLLOW-UP OF
MAGLE
GROUP’S INNOVATIVE MEDICAL DEVICE SMARTPAN® PRESENTED AT
SCIENTIFIC CONGRESS
* STUDY RESULTS CONFIRM USABILITY AND SAFETY OF SMARTPAN®
WHEN
USED AS AN INDICATOR OF PANCREATIC LEAKAGE
Source text for Eikon: ID:nMFN2jw5Gl
Further company coverage: MAGLE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Magle Chemoswed Holding AB
See all newsBrief: Magle Group Updates On Financing Restructuring, Proposed Share Issuance
Brief: Magle Chemoswed Q1 EBIT SEK -17.8 Million
Sweden's Magle Chemoswed posts Q4 loss on restructuring measures
Brief: Magle Chemoswed Q4 EBIT SEK -120.3 Million
Brief: Magle Group Begins Written Procedure For Amendments, Waivers To Bond Terms